Editorial assistance, redrawing figures, and formatting was provided by Carolyn Bowler, PhD, CMPP, of Apollo, OPEN Health Communications, and funded by Novo Nordisk A/S, in accordance with Good Publication Practice guidelines
Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for Clinical Practice
S.HuangH
E, diferente do que muita gente imagina, o mais caro nem sempre o melhor, assim como o mais barato quase nunca entrega o que promete
Early changes in blood urea nitrogen (BUN) can predict mortality in acute pancreatitis: comparative study between BISAP Score, APACHE-II, and other laboratory markers-a prospective observational study